Cited by 254T-cell and B-cell ImmunologyRenal Transplantation Outcomes and TreatmentsSignaling Pathways in Disease

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Open access

Coenen, Jeroen J. A., Koenen, Hans J. P. M., van Rijssen, Esther, Hilbrands, Luuk B., Joosten, Irma·2006·Blood

DOI 10.1182/blood-2005-07-3032

Open this paper in CoChat — free account Open PDF

Abstract

The immunosuppressive drugs rapamycin and cyclosporin A (CsA) are widely used to prevent allograft rejection. Moreover, they were shown to be instrumental in experimental models of tolerance induction. However, it remains to be elucidated whether these drugs have an effect on the CD4+ CD25+ regulatory T-cell (T(REG)) population, which plays an important role in allograft tolerance. Recently, we reported that alloantigen-driven expansion of human CD4+ CD25+ T(REG)s gives rise to a distinct highly suppressive CD27+ T(REG) subset next to a moderately suppressive CD27- T(REG) subset. In the current study we found that rapamycin and CsA do not interfere with the suppressive activity of human naturally occurring CD4+ CD25+ T cells. However, in contrast to CsA, rapamycin preserved the dominance of the potent CD27+ T(REG) subset over the CD27- T(REG) subset after alloantigen-driven expansion of CD4+ CD25+ T(REG)s in vitro. Accordingly, CD4+ CD25+ T(REG)s cultured in the presence of rapamycin displayed much stronger suppressive capacity than CD4+ CD25+ T(REG)s cultured in the presence of CsA. In addition, CD4+ CD25+ T(REG) cells cultured in the presence of rapamycin, but not CsA, were able to suppress ongoing alloimmune responses. This differential effect of rapamycin and CsA on the CD27+ T(REG) subset dominance may favor the use of rapamycin in tolerance-inducing strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2005-07-3032

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature reviews. Immunology · doi:10.1038/nri821 · Cited by 2,097
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature reviews. Immunology · doi:10.1038/nri1027 · Cited by 1,319
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S., & Negrin, R. S. (2003) · Nature Medicine · doi:10.1038/nm915 · Cited by 1,286
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K., Bi, M., Finger, E. B., Szot, G. L., Ye, J., Masteller, E. L., McDevitt, H. O., Bonyhadi, M. L., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,232
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.
Battaglia, M., Stabilini, A., & Roncarolo, M. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,203
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature reviews. Immunology · doi:10.1038/nri1148 · Cited by 863
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
Li, Y.-S., Li, X.-C., Zheng, X., Wells, A., Turka, L., & Strom, T. (1999) · Nature Medicine · doi:10.1038/15256 · Cited by 830
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1435 · Cited by 819
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A., Morris, P. J., Powrie, F. M., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 765
CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses
Kingsley, C. I., Karim, M., Bushell, A., & Wood, K. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1080 · Cited by 742

Show all 38 references

Sorted by citations

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T. E., Levine, B. L., June, C. H., Rubinstein, P., et al. (2010) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,052
Immunoregulatory functions of mTOR inhibition
Thomson, A. W., Turnquist, H. R., & Raimondi, G. (2009) · Nature reviews. Immunology · doi:10.1038/nri2546 · Cited by 873
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs‐Hoeck, J., Kaupper, T., & Roncarolo, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 746
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Jagasia, M., Arora, M., Flowers, M. E. D., Chao, N. J. A., McCarthy, P. L., Cutler, C. S., Urbano-Ispizúa, Á., Pavletic, S. Z., Haagenson, M. D., Zhang, M., et al. (2011) · Blood · doi:10.1182/blood-2011-06-364265 · Cited by 706
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Zeiser, R., Nguyen, V. H., Beilhack, A., Buess, M., Schulz, S., Baker, J. B., Contag, C. H., & Negrin, R. S. (2006) · Blood · doi:10.1182/blood-2006-01-0329 · Cited by 511
Next-generation regulatory T cell therapy
Ferreira, L. M. R., Müller, Y. D., Bluestone, J. A., & Tang, Q. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0041-4 · Cited by 491
Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance
Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z., & Thomson, A. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7018 · Cited by 442
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Rezvani, K., Mielke, S., Ahmadzadeh, M., Kilical, Y., Savani, B. N., Zeilah, J., Keyvanfar, K., Montero, A., Hensel, N. F., Kurlander, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-003996 · Cited by 368
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T regs ) with Minimal Loss of in Vivo Functional Activity
Hippen, K. L., Merkel, S. C., Schirm, D. K., Sieben, C. M., Sumstad, D., Kadidlo, D. M., McKenna, D. H., Bromberg, J. S., Levine, B. L., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001809 · Cited by 367
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Kanakry, C. G., Ganguly, S., ZAHURAK, M. L., Bolaños‐Meade, J., Thoburn, C. J., Perkins, B. N., Fuchs, E. J., Jones, R. J., Hess, A. D., & Luznik, L. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006960 · Cited by 365
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin
Strauss, L., Whiteside, T. L., Knights, A. J., Bergmann, C., Knuth, A. K., & Zippelius, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.320 · Cited by 339
Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair
Nieuwenhuijs‐Moeke, G. J., Pischke, S. E., Berger, S. P., Sanders, J., Pol, R. A., Struys, M. M. R. F., Ploeg, R. J., & Leuvenink, H. G. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010253 · Cited by 336
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy
Buchan, S. L., Rogel, A., & Al‐Shamkhani, A. (2017) · Blood · doi:10.1182/blood-2017-07-741025 · Cited by 282
Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen-Specific Regulatory T Cells
Gao, W., Lu, Y., Essawy, B. E., Oukka, M., Kuchroo, V. K., & Strom, T. B. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01842.x · Cited by 260
The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor
Damoiseaux, J. G. M. C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108515 · Cited by 253
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy
Haanen, J., Ernstoff, M. S., Wang, Y., Menzies, A. M., Puzanov, I., Grivas, P., Larkin, J., Peters, S., Thompson, J. A., & Obeid, M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.285 · Cited by 222
NFAT pulls the strings during CD4+ T helper cell effector functions
Hermann-Kleiter, N., & Baier, G. (2010) · Blood · doi:10.1182/blood-2009-10-233585 · Cited by 218
Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin
Basu, S., Golovina, T. N., Mikheeva, T., June, C. H., & Riley, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5794 · Cited by 183
Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
Gordon, J., Ma, Y., Churchman, L., Gordon, S. A., & Dawicki, W. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00007 · Cited by 184
Functional characterization of CD4+ T cells in aplastic anemia
Kordasti, S. Y., Marsh, J. C. W., Al-Khan, S., Jiang, J., Smith, A., Mohamedali, A. M., Abellan, P. P., Veen, C., Costantini, B., Kulasekararaj, A. G., et al. (2011) · Blood · doi:10.1182/blood-2011-08-368308 · Cited by 176
Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
Okubo, Y., Mera, T., Wang, L., & Faustman, D. L. (2013) · Scientific Reports · doi:10.1038/srep03153 · Cited by 171
CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath-1H
Bloom, D. D., Chang, Z., Fechner, J. H., Dar, W. A., Polster, S. P., Pascual, J., Turka, L. A., & Knechtle, S. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02134.x · Cited by 170
Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
Strauss, L., Czystowska, M., Szajnik, M. E., Mandapathil, M., & Whiteside, T. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005994 · Cited by 170
CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth
Claus, C., Riether, C., Schürch, C. M., Matter, M. S., Hilmenyuk, T., & Ochsenbein, A. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2791 · Cited by 167
Regulatory T cells in many flavors control asthma
Ray, A., Khare, A., Krishnamoorthy, N., Qi, Z., & Ray, P. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.4 · Cited by 167
CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R., Balcarcel, R. R., Fisher, N. C., Levine, B. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2855 · Cited by 166
Transplantation immunology: Solid organ and bone marrow
Chinen, J., & Buckley, R. H. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.014 · Cited by 168
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells
Hippen, K. L., Harker-Murray, P. D., Porter, S. B., Merkel, S. C., Londer, A., Taylor, D. K., Bina, M., Panoskaltsis‐Mortari, A., Rubinstein, P., van Rooijen, N., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132951 · Cited by 143
Improving Engraftment and Immune Reconstitution in Umbilical Cord Blood Transplantation
Danby, R., & Rocha, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00068 · Cited by 129
De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR
Kang, J., Huddleston, S. J., Fraser, J. M., & Khoruts, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207851 · Cited by 126
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
Safinia, N., Scottà, C., Vaikunthanathan, T., Lechler, R. I., & Lombardi, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00438 · Cited by 119
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
Schaer, D., Hirschhorn-Cymerman, D., & Wolchok, J. D. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-7 · Cited by 121
In vitro effects of cyclosporine a and tacrolimus on regulatory T-cell proliferation and function
Miroux, C., Morales, O., Ghazal, K., Othman, S. B., de Launoit, Y., Pancré, V., Conti, F., & Delhem, N. (2012) · Transplantation · doi:10.1097/tp.0b013e3182590d8f · Cited by 117
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
van der Waart, A. B., van de Weem, N. M. P., Maas, F., Kramer, C. S. M., Kester, M. G. D., Falkenburg, J. H. F., Schaap, N. P., Jansen, J. H., van der Voort, R., Gattinoni, L., et al. (2014) · Blood · doi:10.1182/blood-2014-05-578583 · Cited by 116
Variation in numbers of CD4+CD25highFOXP3+T cells with normal immuno-regulatory properties in long-term graft outcome
Braudeau, C., Racapé, M., Giral, M., Louis, S., Moreau, A., Berthelot, L., Heslan, M., Ashton‐Chess, J., Soulillou, J., & Brouard, S. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00537.x · Cited by 116
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance
Obregon, C., Kumar, R., Pascual, M. A., Vassalli, G., & Golshayan, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01514 · Cited by 111
The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model
Ueno, T., Habicht, A., Clarkson, M. R., Albin, M. J., Yamaura, K., Boenisch, O., Popoola, J., Wang, Y., Yagita∥, H., Akiba, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32451 · Cited by 105
Clinical perspectives for regulatory T cells in transplantation tolerance
Hippen, K. L., Riley, J. L., June, C. H., & Blazar, B. R. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.008 · Cited by 103
Impact of Immunosuppressive Drugs on CD4+CD25+FOXP3+ Regulatory T Cells
Demirkıran, A., Hendrikx, T. K., Baan, C. C., & van der Laan, L. J. W. (2008) · Transplantation · doi:10.1097/tp.0b013e318166910b · Cited by 103
Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy
Urak, R. Z., Walter, M., Lim, L., Wong, C. W., Budde, L. E., Thomas, S. H., Forman, S. J., & Wang, X. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0227-4 · Cited by 102
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Pidala, J., Kim, J., Jim, H., Kharfan‐Dabaja, M. A., Nishihori, T., Fernandez, H. F., Tomblyn, M. R., Perez, L. E., Perkins, J. B., Xu, M., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.067140 · Cited by 98
Immune suppressive properties of artemisinin family drugs
Hou, L., & Huang, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.002 · Cited by 97
Use of Rapamycin in the Induction of Tolerogenic Dendritic Cells
Fischer, R. T., Turnquist, H. R., Taner, T., & Thomson, A. W. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_10 · Cited by 95
Clinical application of expanded CD4+25+ cells
June, C. H., & Blazar, B. R. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.006 · Cited by 95
Following Anti-CD25 Treatment, A Functional CD4+CD25+ Regulatory T-Cell Pool Is Present in Renal Transplant Recipients
Kreijveld, E., Koenen, H. J. P. M., Klasen, I., Hilbrands, L. B., & Joosten, I. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01604.x · Cited by 90
Self-citation
Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion
Horibe, E. K., Sacks, J. M., Unadkat, J., Raimondi, G., Wang, Z., Ikeguchi, R., Marsteller, D. A., Ferreira, L. M., Thomson, A. W., Lee, W. P. A., et al. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.10.007 · Cited by 89
Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells
Demirkıran, A., Sewgobind, V. D. K. D., van der Weijde, J., Kok, A., Baan, C. C., Kwekkeboom, J., Tilanus, H. W., Metselaar, H. J., & van der Laan, L. J. W. (2009) · Transplantation · doi:10.1097/tp.0b013e31819d2032 · Cited by 87
Ex vivo expansion of CD4+CD25+ T regulatory cells for immunosuppressive therapy
Trzonkowski, P., Szaryńska, M., Myśliwska, J. M., & Myśliwski, A. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20659 · Cited by 85
Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells
Scottà, C., Fanelli, G., Hoong, S.-J., Romano, M., Nova‐Lamperti, E., Sukthankar, M., Guggino, G., Fazekasova, H., Ratnasothy, K., Becker, P. D., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.128934 · Cited by 80
IL-1β-Driven ST2L Expression Promotes Maturation Resistance in Rapamycin-Conditioned Dendritic Cells
Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y., Geller, D. A., & Thomson, A. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.62 · Cited by 78
Immune Regulatory Cells in Umbilical Cord Blood and Their Potential Roles in Transplantation Tolerance
Kim, Y.-J., & Broxmeyer, H. (2010) · Critical reviews in oncology/hematology · doi:10.1016/j.critrevonc.2010.07.009 · Cited by 71
Regulatory T cells in human autoimmune diseases
Torgerson, T. R. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0041-4 · Cited by 73
Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses
Struijk, G. H., Minnee, R. C., Koch, S. D., Zwinderman, A. H., der Pant, K. A. M. I. V. D., Idu, M. M., ten Berge, I. J. M., & Bemelman, F. J. (2010) · Kidney International · doi:10.1038/ki.2010.269 · Cited by 71
Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients
Stock, P. G., Barin, B., Hatano, H., Rogers, R., Roland, M. E., Lee, T.-H., Busch, M. P., & Deeks, S. G. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12699 · Cited by 69
The Inhibitory FcγIIb Receptor Dampens TLR4-Mediated Immune Responses and Is Selectively Up-regulated on Dendritic Cells from Rheumatoid Arthritis Patients with Quiescent Disease
Wenink, M. H., Santegoets, K. C. M., Roelofs, M. F., Huijbens, R. J. F., Koenen, H. J. P. M., van Beek, R., Joosten, I., Meyer‐Wentrup, F. A. G., Mathsson, L., Rönnelid, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900153 · Cited by 69
Self-citation
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells
He, X., Landman, S., Bauland, S. C. G., van den Dolder, J., Koenen, H. J. P. M., & Joosten, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156311 · Cited by 69
Self-citation
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway
Stallone, G., Pontrelli, P., Infante, B., Gigante, M., Netti, G. S., Ranieri, E., Grandaliano, G., & Gesualdo, L. (2013) · Kidney International · doi:10.1038/ki.2013.337 · Cited by 66
Immunosuppressive Drugs and Tregs
Serres, S. A. D., Sayegh, M. H., & Najafian, N. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03180509 · Cited by 66
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
Weiß, L., Melchardt, T., Egle, A., Grabmer, C., Greil, R., & Tinhofer, I. (2010) · Cancer · doi:10.1002/cncr.25752 · Cited by 65
CD4+ CD25bright+ Regulatory T Cells Can Mediate Donor Nonreactivity in Long-Term Immunosuppressed Kidney Allograft Patients
Velthuis, J. H. L., Mol, W. M., Weimar, W., & Baan, C. C. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01566.x · Cited by 64
Promoting transplantation tolerance; adoptive regulatory T cell therapy
Safinia, N., Leech, J. M., Hernández-Fuentes, M. P., Lechler, R. I., & Lombardi, G. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12052 · Cited by 64
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function
Kaufmann, U., Shaw, P. J., Kozhaya, L., Subramanian, R., Gaida, K., Unutmaz, D., McBride, H. J., & Feske, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501406 · Cited by 61
The Evolving Role of mTOR Inhibition in Transplantation Tolerance
McMahon, G. M., Weir, M. R., Li, X. C., & Mandelbrot, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040351 · Cited by 60
Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells
Gallon, L. G., Traitanon, O., Yu, Y., Shi, B., Leventhal, J. R., Miller, J., Mas, V. R., Xu, L., & Mathew, J. M. (2015) · Transplantation · doi:10.1097/tp.0000000000000717 · Cited by 59
Signals and pathways controlling regulatory T cells
Huynh, A., Zhang, R., & Turka, L. A. (2014) · Immunological Reviews · doi:10.1111/imr.12148 · Cited by 59
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells
Hornero, R. A., Georgiadis, C., Peng, H., Trzupek, D., He, L.-Z., Qasim, W., Todd, J. A., Ferreira, R. C., Wood, K. J., Issa, F., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1097-8 · Cited by 61
TCR affinity and specificity requirements for human regulatory T-cell function
Plesa, G., Zheng, L., Medvec, A. R., Wilson, C. B., Robles-Oteíza, C., Liddy, N., Bennett, A., Gavarret, J., Vuidepot, A., Zhao, Y., et al. (2012) · Blood · doi:10.1182/blood-2011-09-377051 · Cited by 55
Role of Naturally Arising Regulatory T Cells in Hematopoietic Cell Transplantation
Nguyen, V. H., Zeiser, R., & Negrin, R. S. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.04.009 · Cited by 55
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity
Lam, A. J., Lin, D. T. S., Gillies, J. K., Uday, P., Pesenacker, A. M., Kobor, M. S., & Levings, M. K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109494 · Cited by 52
Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers
Sun, Q., Lin, G., Li, L., Jin, X.-T., Huang, L., Zhang, G., Yang, W. M., Chen, K., Xiang, R., Chen, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00665 · Cited by 52
Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis
Matsuda, C., Ito, T., Song, J., Mizushima, T., Tamagawa, H., Kai, Y., Hamanaka, Y., Inoue, M., Nishida, T., Matsuda, H., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03345.x · Cited by 52
GPA33: A Marker to Identify Stable Human Regulatory T Cells
Opstelten, R., de Kivit, S., Slot, M. C., van den Biggelaar, M., Iwaszkiewicz‐Grześ, D., Gliwiński, M., Scott, A. M., Blom, B., Trzonkowski, P., Borst, J. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901250 · Cited by 54
Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo
Wu, T., Zhang, L., Xu, K., Sun, C., Lei, T. B., Peng, J., Liu, G., Wang, R., & Zhao, Y. X. (2012) · Transplant Immunology · doi:10.1016/j.trim.2012.05.001 · Cited by 50
Inducing and Administering Tregs to Treat Human Disease
Perdigoto, A. L., Chatenoud, L., Bluestone, J. A., & Herold, K. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00654 · Cited by 51
Regulatory T Cells Exhibit Decreased Proliferation but Enhanced Suppression After Pulsing With Sirolimus
Singh, K., Kozyr, N. L., Stempora, L., Kirk, A. D., Larsen, C. P., Blazar, B. R., & Kean, L. S. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03963.x · Cited by 49
Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells
Lim, D., Joe, I.-Y., Park, Y.-H., Chang, S.-H., Wee, Y., Han, D., & Kim, S. C. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.005 · Cited by 49
Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients
Latorre, I., Esteve‐Solé, A., Redondo‐Pachón, D., Giest, S., Argilaguet, J. M., Álvarez, S., Peligero, C., Forstmann, I., Crespo, M., Pascual, J., et al. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.01.004 · Cited by 49
Impact of Immunosuppressants on the Therapeutic Efficacy of In Vitro-Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Allotransplantation
Lim, D., Koo, S.-K., Park, Y.-H., Kim, Y., Kim, H., Park, C.-S., Kim, S. C., & Han, D. (2010) · Transplantation · doi:10.1097/tp.0b013e3181d3c9d4 · Cited by 48
Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor–based drug regimens
Presser, D., Sester, U., Mohrbach, J., Janssen, M., Köhler, H., & Sester, M. (2009) · Kidney International · doi:10.1038/ki.2009.198 · Cited by 48
Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
Chung, B. H., Kim, K., Kim, B., Doh, K. C., Cho, M., & Yang, C. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145258 · Cited by 48
Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation
Macedo, C., Turquist, H., Metes, D., & Thomson, A. W. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-16 · Cited by 47
Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys
Ma, A., Qi, S., Song, L., Hu, Y., Dun, H., Massicotte, E., Dupuis, M., Daloze, P., & Chen, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.001 · Cited by 46
Tregs in transplantation tolerance: role and therapeutic potential
Cassano, A., Chong, A. S., & Alegre, M. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1217065 · Cited by 45
An Autocrine TNFα–Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability In Vitro
Urbano, P. C. M., Koenen, H. J. P. M., Joosten, I., & He, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00573 · Cited by 48
Self-citation
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
Bejanyan, N., Pidala, J. A., Wang, X., Thapa, R., Nishihori, T., Elmariah, H., Lazaryan, A., Khimani, F., Davila, M. L., Mishra, A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003779 · Cited by 44
Immune modulation and chronic graft-versus-host disease
Soiffer, R. J. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.119 · Cited by 44
The Influence of Immuosuppressive Therapy on the Development of CD4+CD25+ T Cells After Renal Transplantation
Korczak-Kowalska, G., Wierzbicki, P., Bocian, K., Kłosowska, D., Niemczyk, M., Wyzgał, J., Korecka, A., Durlik, M., Chmura, A., Pączek, L., et al. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.09.015 · Cited by 44
Engineered Treg cells: The heir to the throne of immunotherapy
Stucchi, A., Maspes, F., Montee-Rodrigues, E., & Fousteri, G. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102986 · Cited by 43
1α,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3
Morales-Tirado, V. M., Wichlan, D., Leimig, T., Street, S. E. A., Kasow, K. A., & Riberdy, J. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.003 · Cited by 43
Regulatory T Cells in Kidney Transplantation: New Directions?
Braza, F., Durand, M., Degauque, N., & Brouard, S. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13395 · Cited by 44
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non‐human primate xenotransplantation model
Porter, C. M., Horvath‐Arcidiacono, J. A., Singh, A. K., Horvath, K. A., Bloom, E. T., & Mohiuddin, M. M. (2007) · Xenotransplantation · doi:10.1111/j.1399-3089.2007.00416.x · Cited by 43
Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation
Wang, Z., Shi, B.-Y., Qian, Y.-Y., Cai, M., & Wang, Q. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03847.x · Cited by 42
Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
Keever-Taylor, C. A., Browning, M. B., Johnson, B., Truitt, R. L., Bredeson, C., Behn, B., & Tsao, A. (2007) · Cytotherapy · doi:10.1080/14653240601145223 · Cited by 42
Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells
Tjon, A. S. W., Tha‐In, T., Metselaar, H. J., van Gent, R., van der Laan, L. J. W., Groothuismink, Z. M. A., Boekhorst, P. A. W. T., van Hagen, P. M., & Kwekkeboom, J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12102 · Cited by 41
Rapamycin Protects Mice from Staphylococcal Enterotoxin B-Induced Toxic Shock and Blocks Cytokine ReleaseInVitroandIn Vivo
Krakauer, T., Buckley, M. J., Issaq, H. J., & Fox, S. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01015-09 · Cited by 41
T Regulatory Cells Play a Significant Role in Modulating MHC Class I Antibody-Induced Obliterative Airway Disease
Tiriveedhi, V., Takenaka, M., Ramachandran, S., Gelman, A. E., Subramanian, V., Patterson, G. A., & Mohanakumar, T. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04191.x · Cited by 40
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors
Meloni, F., Morosini, M., Solari, N., Bini, F., Vitulo, P., Arbustini, E., Pellegrini, C., & Fietta, A. M. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.07.019 · Cited by 40
Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells
Iwami, D., Nonomura, K., Shirasugi, N., & Niimi, M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.035 · Cited by 39
Adoptive regulatory T cell therapy: challenges in clinical transplantation
Safinia, N., Sagoo, P., Lechler, R. I., & Lombardi, G. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833bfadc · Cited by 40
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Hyder, M. A., Dimitrova, D., Sabina, R., DeVries, A., McCune, J. S., McAdams, M. J., Flomerfelt, F. A., McKeown, C., Sadler, J. L., Chai, A., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014879 · Cited by 38

Authors: Coenen, J. J. A., Koenen, H. J. P. M., van Rijssen, E., Hilbrands, L. B., & Joosten, I.
Affiliations: Radboud University Medical Center (NL)
From the Department of Bloodtransfusion and Transplantation Immunology and the Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
ORCID: Koenen, Hans J. P. M.
Hilbrands, Luuk B.
Joosten, Irma
Venue: Blood
Publisher: American Society of Hematology
Published: 2006-02-01
Volume: 107
Issue: 3
Pages: 1018-1023
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2005-07-3032
OpenAlex: W1972290737
Cited by: 252
References: 38
Citations by year: 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 14 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 8 · 2012: 21
FWCI: 8.16
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Funders: Nierstichting
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords: rapamycin, cyclosporine, regulatory T cells, CD4+CD25+ T cells, immunosuppressants, allograft tolerance, suppressor activity, mTOR inhibition
MeSH terms: Cells, Cultured, Dose-Response Relationship, Drug, Graft Rejection, Humans, Immune Tolerance, Immunosuppressive Agents, Isoantigens, Lymphocyte Activation, Transplantation, Homologous, Cyclosporine, Tumor Necrosis Factor Receptor Superfamily, Member 7, Sirolimus, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks